CCadwell designs and sells medical neurophysiology equipment, consumables, and software for electrodiagnostic testing, covering EMG, IONM, EEG, and sleep studies. It captures electrical signals with sensors and electrodes, then Cadwell hardware amplifies, records, and CadLink software analyzes the data to support diagnosis and monitoring. The company differentiates itself with a long history of customer feedback, an integrated line of hardware, consumables, and software, and its CadLink data management platform. Its goal is to help clinicians assess nervous system function more reliably so patients receive better care.
Work here?Claim your company
Industries
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
Kennewick, WA
Founded
1979
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Cadwell Industries has appointed Jeff Cohen as chief executive officer, succeeding Patrick Jensen, who is stepping down after 10 years in the role. Cohen, a medical technology veteran with over 20 years of experience, previously served as senior vice president and general manager of Philips Ultrasound. During Jensen's tenure, Cadwell expanded its neurodiagnostics footprint, entered the epilepsy monitoring market, and made strategic investments in Sleepmate and Seer Medical. Jensen will remain with the Kennewick, Washington-based company as a strategic adviser. Cohen holds degrees from Worcester Polytechnic Institute and Boston College, plus an executive management certificate from MIT. He will lead Cadwell's continued focus on neurodiagnostic, neuromonitoring, and sleep solutions for clinicians worldwide.
Cadwell names Jeff Cohen CEO, succeeding Patrick Jensen. KENNEWICK, Wash., Sept. 10, 2026 - Cadwell Industries, Inc. today announced that Patrick Jensen, Ph.D., will step down as chief executive officer, concluding a 10-year tenure in the role. Jeff Cohen, a seasoned medical technology executive, will succeed Jensen as Cadwell's CEO, effective immediately. Jensen will remain with the company as a strategic advisor. "I want to thank Patrick for his decade of leadership," said John Cadwell Jr., chairman of the board and president of Cadwell. "He oversaw tremendous growth during his tenure while maintaining Cadwell's motto of, 'Helping you help others.' Patrick approached us about scaling back to spend more time with his family about a year ago. I appreciate his commitment to helping us find a successor, ensuring a seamless handoff and continuing to be involved at Cadwell in an advisory capacity. We are equally excited to welcome Jeff to Cadwell and are confident his experience will build one everything Patrick helped us achieve." During his tenure, Jensen expanded Cadwell's footprint as a leader in neurodiagnostics, guided by a deep commitment to the clinicians using Cadwell equipment and the patients they serve. He grew the company's global market presence, led its entry into the epilepsy monitoring market and strengthened its innovation portfolio through strategic investments in Sleepmate(R) and Seer Medical. He also led the development and release of new solutions shaped by direct physician and technologist feedback, including the Cadwell Guardian(R) IONM system. "I'm grateful to have worked with the Cadwell team and our amazing network of physicians and technicians for the past 10 years. We have made significant progress toward our mission of improving the lives of neurology patients around the world, and I am confident that Jeff is the right leader to guide Cadwell going forward. I look forward to remaining engaged as a strategic advisor at Cadwell to ensure a smooth transition and help continue our trajectory of growth and positive impact on the neurology community," said Jensen. Cohen brings more than 20 years of medical technology industry experience spanning global business strategy, research and development, product innovation and commercial sales. Much of that time was at Philips, where he rose from program manager to senior vice president and general manager of Philips Ultrasound, leading global teams that grew market share while expanding margins. He holds a bachelor's degree in chemical engineering from Worcester Polytechnic Institute, an MBA from Boston College and an executive management certificate from MIT. With Cohen now leading Cadwell, the company remains focused on its vision: to help more patients globally than any other neurodiagnostics solution provider. "I look forward to building on the track record established by Patrick, the Cadwell team and the Cadwell family," said Cohen. "It is an honor and privilege to lead Cadwell in the next phase of growth, carrying forward the company's strong legacy of helping neurology patients in their time of need." About Cadwell Cadwell is a global medical technology and services company dedicated to delivering innovative neurodiagnostic, neuromonitoring and sleep solutions to clinicians worldwide. Headquartered in Kennewick, Washington, the company provides exceptional support for every stage of the care delivery journey. Media Contact Christina Nelson Director of Marketing 253-453-1791 [email protected]
Cadwell Industries has launched Cadwell Guardian, a next-generation intraoperative neuromonitoring system, in the United States. The platform features a pod-based architecture that scales from routine to complex surgical cases, supporting up to 80 recording channels with 16 mid-current and four low-current outputs. Powered by Cascade Surgical Studio 4.0 software, the system includes detachable components designed for faster setup and easier serviceability. The SMX-32 EEG amplifier enables seamless switching between recording and stimulation for cortical and subcortical mapping. Hardware-based licensing ties to the base unit rather than the PC, allowing equipment refreshes without re-licensing. Cadwell Guardian joins Cascade PRO and Cascade IOMAX in the company's intraoperative neuromonitoring portfolio. The system was showcased at the American Society of Neurophysiological Monitoring 2026 Annual Meeting in Washington, D.C.
Cadwell launches Cadwell Guardian IONM system in the united states. PR Newswire KENNEWICK, Wash., May 13, 2026 /PRNewswire/ - Cadwell Industries, Inc., today announced the U.S. commercial launch of Cadwell Guardian(TM), a next-generation intraoperative neuromonitoring (IONM) platform built around an innovative pod-based architecture that scales from routine to complex surgical cases. Powered by Cascade Surgical Studio(R) 4.0 software, Cadwell Guardian delivers advanced recording and stimulation capabilities, alongside new workflow features that aid in saving time and simplifying the OR experience for IONM providers. As surgical volumes and case complexity continue to rise, IONM plays a critical role in helping surgical teams monitor and protect the brain, spinal cord and peripheral nerves. Cadwell Guardian was engineered to meet that growing demand with durable components that detach at both the system and patient ends, supporting faster setup, efficient turnover and easier serviceability between cases. Anchored by the Cadwell Guardian Base Unit and Power Comm, the system scales up to 80 recording channels with 16 mid-current and four low-current outputs, enabling surgical teams to connect only the modules each case requires. The SMX-32(TM) EEG amplifier enables seamless switching between recording and stimulation for cortical and subcortical mapping in a single device. Optional auditory and visual stimulation modules support comprehensive evoked potential testing. Two further innovations set Cadwell Guardian apart. Hardware-based licensing is tied to the base unit rather than the PC, allowing customers to swap or refresh PCs without re-licensing. Separately, the new System Status view gives clinical teams real-time visibility into device, network and PC health. Backed by more than two decades of IONM innovation, Cadwell Guardian joins Cascade PRO(R) and Cascade(R) IOMAX(R) in Cadwell's IONM portfolio, sharing the Cadwell IONM electrode and accessory ecosystem and CadCare(R) support. "Cadwell Guardian was designed in close collaboration with experienced IONM professionals and underwent rigorous validation across a broad range of surgical cases to ensure reliability, precision and ease of use," said Patrick Jensen, Ph.D., CEO of Cadwell. "Cadwell remains committed to delivering innovative, clinician-driven solutions that elevate standards in neuromonitoring. With Cadwell Guardian, we are not only responding to the current demands of the OR - we are building the foundation for the future of IONM." Cadwell will showcase Cadwell Guardian at the American Society of Neurophysiological Monitoring (ASNM) 2026 Annual Meeting, May 15-17, 2026, at the Omni Shoreham Hotel in Washington, D.C., booths 29 and 30. Attendees can experience the system hands-on alongside the full Cadwell IONM family.
Seer Medical has been revived from voluntary administration thanks to a $40 million investment deal involving Breakthrough Victoria.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
Kennewick, WA
Founded
1979
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs